We identified genetic instruments based on the meta-analyzed summary statistics from the stroke multi-ancestry genome wide association study [GCST005838 (67,162 cases and 454,450 controls)] and the International League Against Epilepsy Consortium on Complex Epilepsies [Generalized epilepsy: GCST007343 (n_case=3769, n_control=29677), Focal epilepsy: GCST007352 (n_case=9671, n_control=29677)]. We included the following epilepsy subtypes (only available for Caucasian patients): generalized epilepsy (GE), focal epilepsy (FE), childhood absence epilepsy (CAE), juvenile absence epilepsy (JAE), juvenile myoclonic epilepsy (JME), generalized epilepsy with tonic-clonic seizures (GTCS), focal epilepsy with hippocampal sclerosis (FHS), and focal lesion-negative epilepsy (FLNE). Analysis was restricted to independent variants. Variants of potential reverse causality were removed. For causal effect estimation we used the inverse-variance weighted estimate (IVW), MR-Egger, MR-RAPS, and MRPRESSO.